Mankind Pharma Ltd and Innovent Biologics have partnered to license and commercialise the cancer immunotherapy drug Sintilimab in India. They aim to enhance cancer treatment and patient access to innovative therapies. Mankind Pharma plans to seek regulatory approval in 2024 and perform essential clinical trials in India.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ojmvWJK
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2024
(861)
-
▼
December
(65)
- Erring drug companies to face stricter action as r...
- IBC turns lifeline for hospitals: Investors snap u...
- #25 For 2025: What will it take to ease the pain o...
- Will we succeed in making low medical bills a real...
- Why investing in healthcare is vital?
- Blackstone, Carlyle and other PEs submit bids to u...
- Home delivery of medicines from Railway-run hospit...
- Bengaluru: Trustwell Hospitals plans 100-bed expan...
- “Fear of heart disease” drives surge in cardiac CT...
- RIL buys Karkinos Health for Rs 375 crore
- People single all their lives might have low life ...
- 111 drug samples tested in November found 'not of ...
- Low conviction rate of cases related to fake drugs...
- Addressing “Metabolic Syndrome”: Key to tackling ...
- Chemists selling spurious meds may face prosecution
- Mankind Pharma inks licensing pact with Innovent t...
- Akums enters into Rs 1750 crore contract to supply...
- Drinking tea, coffee linked to lower risk of head ...
- Mankind Pharma partners with Innovent to aid cance...
- This anti-diabetic drug used for weight loss has b...
- NATHEALTH asks govt to address systemic gaps in he...
- Karnataka HC stays action against drug units makin...
- AbbVie Healthcare India rejects wrongdoing allegat...
- Biocon, Zentiva get EU approval for generic diabet...
- AbbVie Healthcare under government lens for 'viola...
- US FDA restricts imports of some Viatris products ...
- Ontario Teachers’ buys into Omega Healthcare
- New list of over the counter drugs soon
- Ontario Teachers' Pension Plan in advanced talks t...
- Zydus Lifesciences gets USFDA nod for generic topi...
- NPPA ropes in patent office to decide on pleas for...
- GIC buys a majority stake in hospital platform Asi...
- Quadria Capital to pick up minority stake in drug ...
- Granules India gets USFDA nod for generic drug
- Indian Pharma and healthcare sectors are poised fo...
- SPARC enters pact with UCSF and Tiller Therapeutic...
- Pharma lobby, govt meet to discuss OTC drug regula...
- Bavarian Nordic inks Mpox vaccine deal with Serum ...
- Zydus Lifesciences acquires 6.5 pc in Mylab Discov...
- Waiting time for orthopaedic surgeries increases a...
- Amid pollution woes, Asthma drug demand drives pha...
- New panel to push Johnson & Johnson to look for mo...
- J&J hip implant victims may soon get compensation
- Cipla gets CDSCO nod to launch inhalation insulin
- Reliance Strategic Business Ventures’ Rs 202 cr pl...
- Govt prescribes faster access to medicines for rar...
- Dr Morepen forays into wellness segment with weigh...
- Popular US-based weight loss drug maker Eli Lilly ...
- Suven Pharma to acquire 56 pc stake in US-based fi...
- Laurus Labs biotech unit raises Rs 120 crore from ...
- A comprehensive approach to diabetes care
- Dr Reddy's unit gets penalty of Rs 28.7 lakh from ...
- Aurobindo unit gets USFDA nod for generic cancer drug
- Foreign investors in love with Indian hospitals, w...
- Nearly 3,000 drugs failed quality test in FY24; 28...
- Kotak Pre-IPO fund to buy into diagnostic chain Ne...
- Carlyle Group sells 4.3% in Indegene for ₹636 cr
- Novo Nordisk India execs urge early Wegovy launch ...
- Parents challenge Covid vaccine safety in Supreme ...
- Flipkart Minutes eyes 10-min drug delivery to outp...
- Milestone for India: Indigenous E-beam technology ...
- Reliance Industries-powered Strand Life Sciences u...
- Internet searches on mental health increased 41% t...
- Biocon Biologics gets US nod to launch Stelara bio...
- Want a slimmer face? Try these 7 easy exercises
-
▼
December
(65)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment